New perspectives on the chemotherapy of malaria, filariasis, and leprosy.
D000655:Amodiaquine / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D003408:Cresols / Q000627:therapeutic use; D003622:Dapsone / Q000032:analysis / Q000627:therapeutic use; D004351:Drug Resistance; D005368:Filariasis / Q000188:drug therapy*; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000517:prevention & control; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control; D010627:Phenethylamines / Q000627:therapeutic use; D010963:Plasmodium falciparum; D011759:Pyrrolidines / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use*; D012545:Schiff Bases / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
D000814:Aniline Compounds; D000962:Antimalarials; D003408:Cresols; D005493:Folic Acid Antagonists; D006146:Guanidines; D010627:Phenethylamines; D011759:Pyrrolidines; D011799:Quinazolines; D011804:Quinolines; D012545:Schiff Bases; D013450:Sulfones; D000655:Amodiaquine; D002738:Chloroquine; D003622:Dapsone